The BETTER4U project (Preventing Obesity through Biologically and bEhaviorally Tailored inTERventions for You) is a Horizon Europe initiative (GAP 101080117) dedicated to advancing our understanding of the multifaceted etiology of obesity. The project aims to move beyond current knowledge of obesity-related determinants by examining the system-level interactions between biological (including genetics), lifestyle behaviors (physical activity, nutrition, sedentary behaviors), and contextual factors, including social, economic, psychological, and environmental factors. BETTER4U advances from traditional approaches by exploring determinants embedded within interconnected systems and biological frameworks. It seeks to identify and integrate polygenic risks, omics-based markers, lifestyle and contextual factors using data from biobanks and previous landmark studies. This comprehensive approach enables the refinement of Artificial Intelligence (AI) algorithms, enhancing individualization in the design of tailored interventions. The project employs real-time behavioral monitoring tools and remote technologies to track individual behaviors and metabolic responses, allowing for the development of personalized obesity prevention strategies. By doing so, BETTER4U aims to bridge the gap between research and practical application, enabling the design of interventions that are biologically and behaviorally informed. The anticipated outcomes of BETTER4U include advanced AI models that support the development of sophisticated, targeted interventions for individuals at risk of overweight or obesity. These models will provide actionable insights into how personalized lifestyle adjustments in lifestyle behaviors, such as diet and physical activity, can effectively mitigate weight gain trajectories across the lifespan. Ultimately, the project seeks to empower individuals and support precision medicine approaches in obesity prevention and treatment through active participant engagement.
Objectives: Obesity and overweight pose a global health and economic burden. Lifestyle interventions are recommended as first‐line treatment. Given their individual complexity, personalized lifestyle interventions may be more effective than one‐size‐fits‐all approaches. This review assessed the methodology, findings and reporting quality of cost‐effectiveness analyses evaluating personalized lifestyle interventions in adults with overweight or obesity. Methods: MEDLINE, Embase, Web of Science, and Scopus were searched in March 2025, with backward reference tracking. Full economic evaluations were included without date restrictions. Studies were categorized by highest applicable personalization level: behavioral (Level 1), phenotype‐based (Level 2), or omics‐based (Level 3). Reporting quality was assessed using the CHEERS 2022 Checklist. Results: From 15,385 records screened, 18 studies were included. Fourteen evaluated Level 1 interventions and two each evaluated Levels 2 and 3. Thirteen were cost‐utility analyses: seven reported cost‐effective or dominant findings, four reported not cost‐effective findings, and two reported unclear or mixed results. Ten studies reported cost‐effectiveness using clinical outcomes: eight showed favorable findings for at least one outcome, and two reported unclear findings. Heterogeneity in intervention design and methods between studies precluded robust conclusions. Findings for level 1 were mixed, evidence for levels 2 and 3 was limited, with favorable and inconsistent findings, respectively. Conclusions: Evidence on the cost‐effectiveness of personalized lifestyle interventions was mixed and predominantly behavioral personalization. The scarcity of economic evaluations evaluating more advanced personalized lifestyle interventions remains a key evidence gap. Future research should evaluate their added value to inform resource allocation in obesity management.